Search

Search Constraints

You searched for: Author/Creator Hamblin, Angela

Search Results

1. A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL. Issue 4 (9th September 2019)

2. Colorectal Cancer Stratification in the Routine Clinical Pathway: A District General Hospital Experience. Issue 6 (July 2019)

4. Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene‐CanVar and the NHS England Haematological Oncology Working Group. (6th February 2023)

6. Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis. Issue 3 (27th June 2020)

8. The 100 000 Genomes Project: bringing whole genome sequencing to the NHS. (24th April 2018)

9. The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions (Editorial, p. 6). Issue 1 (1st November 2018)

10. The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions. Issue 1 (1st November 2018)